STAGE I PROSTATE CANCER AJCC V8
Clinical trials for STAGE I PROSTATE CANCER AJCC V8 explained in plain language.
Never miss a new study
Get alerted when new STAGE I PROSTATE CANCER AJCC V8 trials appear
Sign up with your email to follow new studies for STAGE I PROSTATE CANCER AJCC V8, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Vitamin d may shield bones from hormone therapy side effects
Disease control Recruiting nowThis study tests whether high-dose vitamin D can prevent bone loss caused by hormone therapy (ADT) in older men with prostate cancer. About 240 men aged 50+ who are starting or recently started ADT will take either high-dose vitamin D or a placebo for a year. Researchers will mea…
Matched conditions: STAGE I PROSTATE CANCER AJCC V8
Phase: PHASE3 • Sponsor: University of Rochester • Aim: Disease control
Last updated May 17, 2026 04:17 UTC
-
Testosterone therapy may improve life for men with prostate cancer on watchful waiting
Disease control Recruiting nowThis study looks at whether testosterone replacement therapy (TRT) is safe and beneficial for men with low-risk prostate cancer who are on active surveillance (watchful waiting). Many men with low testosterone avoid TRT due to fears it might worsen their cancer, but this trial ai…
Matched conditions: STAGE I PROSTATE CANCER AJCC V8
Phase: PHASE4 • Sponsor: Roswell Park Cancer Institute • Aim: Disease control
Last updated May 17, 2026 04:16 UTC
-
Sound waves zapping prostate tumors without surgery?
Disease control Recruiting nowThis trial tests a procedure called TULSA that uses MRI-guided sound waves to heat and destroy prostate cancer cells. It is for men aged 45-80 with low to intermediate grade prostate cancer that hasn't spread. The goal is to see if this approach can control the cancer while helpi…
Matched conditions: STAGE I PROSTATE CANCER AJCC V8
Phase: NA • Sponsor: Mayo Clinic • Aim: Disease control
Last updated May 15, 2026 11:54 UTC
-
New drug combo aims to stop prostate cancer spread in high-risk patients
Disease control Recruiting nowThis study tests whether adding a drug called apalutamide to standard hormone therapy and radiation can keep prostate cancer from spreading in people whose cancer was found in lymph nodes after prostate removal surgery. About 586 participants will be randomly assigned to get eith…
Matched conditions: STAGE I PROSTATE CANCER AJCC V8
Phase: PHASE3 • Sponsor: NRG Oncology • Aim: Disease control
Last updated May 13, 2026 16:02 UTC
-
New scan may spare prostate cancer patients from extra surgery
Diagnosis Recruiting nowThis study tests whether a new type of PET/MRI scan can accurately detect if prostate cancer has spread to nearby lymph nodes. About 50 men with high-risk prostate cancer who are scheduled for prostate removal surgery will receive this scan beforehand. The goal is to see if the s…
Matched conditions: STAGE I PROSTATE CANCER AJCC V8
Phase: NA • Sponsor: Mayo Clinic • Aim: Diagnosis
Last updated May 14, 2026 12:06 UTC
-
New radiation technique aims to cut prostate cancer treatment side effects
Symptom relief Recruiting nowThis study tests a new way to deliver radiation for prostate cancer that hasn't spread. By using real-time tracking to adjust the beam as the prostate moves, doctors hope to reduce urinary and bowel side effects. The study will enroll 80 men with early-stage prostate cancer to se…
Matched conditions: STAGE I PROSTATE CANCER AJCC V8
Phase: NA • Sponsor: Jonsson Comprehensive Cancer Center • Aim: Symptom relief
Last updated May 17, 2026 04:47 UTC
-
Smart radiation for prostate cancer: daily adjustments may cut urinary side effects
Symptom relief Recruiting nowThis study compares two ways of giving stereotactic body radiation therapy (SBRT) for prostate cancer that hasn't spread. In standard SBRT, the radiation plan is fixed. In the new approach, doctors use daily MRI or CT scans to adjust the plan to match the patient's anatomy that d…
Matched conditions: STAGE I PROSTATE CANCER AJCC V8
Phase: NA • Sponsor: Jonsson Comprehensive Cancer Center • Aim: Symptom relief
Last updated May 17, 2026 04:43 UTC
-
Could two radiation doses be as good as five for prostate cancer?
Symptom relief Recruiting nowThis study tests whether a newer, shorter radiation method (adaptive therapy, 2 treatments) causes fewer side effects and maintains quality of life compared to the standard 5-treatment approach for men with localized prostate cancer. About 144 participants will be randomly assign…
Matched conditions: STAGE I PROSTATE CANCER AJCC V8
Phase: NA • Sponsor: Mayo Clinic • Aim: Symptom relief
Last updated May 17, 2026 04:15 UTC
-
Nerve wrap may help men avoid erectile dysfunction after prostate cancer surgery
Symptom relief Recruiting nowThis study tests a special tissue wrap placed on the nerves during prostate removal surgery for men with localized prostate cancer. The wrap aims to reduce common side effects like erectile dysfunction and urine leakage. About 25 men will take part to see if the wrap is safe and …
Matched conditions: STAGE I PROSTATE CANCER AJCC V8
Phase: NA • Sponsor: Mayo Clinic • Aim: Symptom relief
Last updated Apr 29, 2026 15:01 UTC